Bruno Medeiros
Physician · Stanford Health Care
Credentials: · ·
History
- 2019–Present
- 2001–2004
- 1998–2001
- 1994–1998
Doctor of Medicine
Research
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
New England Journal of Medicine · 2017 · 1,902 citations
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Blood · 2017 · 1,232 citations
Functional genomic landscape of acute myeloid leukaemia
Nature · 2018 · 1,111 citations
24 papers
17 papers
16 papers
15 papers · 5 as a fellow
13 papers
13 papers
- EE
11 papers
10 papers
Clinical trials
- 2014–2017
Principal investigator · Terminated · Phase 1
Bruno C. Medeiros
- 2014–2015
Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Terminated · Phase 2
Steven E. Coutre
- 2013
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Withdrawn · Phase 2
Stanford University
- 2011–2014
Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS
Principal investigator · Terminated · Phase 2
Stanford University